The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients

Author(s):  
2015 ◽  
Vol 69 (1) ◽  
pp. 26-29
Author(s):  
Borjanka Taneva ◽  
Dejan Ristevski

Abstract Introduction. Exercise tolerance is one of the life quality parmeters in chronic heart failure patients. The aim of our study was to assess the quality of life of patients with chronic heart failure by estimating their exercise tolerance. Methods. We examined 113 patients with stable chronic heart failure in the period of 18 months. They were divided in two groups, a control group (on conventional therapy of angiotensin-converting enzyme inhibitors and diuretics) and a therapy group (conventional therapy plus beta-blockers). The therapy group was divided into 3 subgroups according to the beta-blocker taken (a Metoprolol Bisoprolol and Carvedilol subgroup). Exercise tolerance was detected by coronary trade-mill stress testing every 6 months (only in patients of NYHA FC II and III), symptoms limited or modified after 6-minutes Bruce test. Results. Our results showed that there was a statistically significant difference between the control group and all the therapy subgroups in NYHA FC, NYHA score and exercise tolerance at the end of the study, but there was no difference among the subgroups. Conclusion. Beta-blockers improve the exercise tolerance as a variable defining quality of life.


2019 ◽  
Vol 25 (6) ◽  
pp. 993-1006 ◽  
Author(s):  
Mandana Moradi ◽  
Fereshteh Daneshi ◽  
Razieh Behzadmehr ◽  
Hosien Rafiemanesh ◽  
Salehoddin Bouya ◽  
...  

2021 ◽  
Author(s):  
Eui-Young Choi ◽  
Jin-Sun Park ◽  
Deulle Min ◽  
Hye Sun Lee ◽  
Jeong-Ah Ahn

Abstract BackgroundThe purpose of this study was to investigate the variables that significantly affect heart failure patients’ quality of life, and particularly, to identify the impact of self-management behavior on the quality of life. MethodsThis retrospective study used heart failure patients’ data from cardiovascular outpatient clinics at two tertiary medical centers in Korea. We enrolled 119 patients who completed echocardiography and stress tests and responded to questionnaires on self-management behavior and quality of life. We collected more data on general and disease-related characteristics and anthropometric and serum blood test results through electronic medical record review. We analyzed data using the classification and regression tree to explore the influencing factors and their characteristics in patients with high and low quality of life. ResultsPatients’ mean age was 74.61 years, and women represented 52.1% of the sample. It showed that the cardiac systolic function (β = 0.26, p = .013) and self-management behavior (β = 0.20, p = .048) were two major influential factors on heart failure patients’ quality of life. Therefore, HF patients’ self-management behavior is a significant modifiable factor that can improve their quality of life.ConclusionsHealthcare providers should be aware of the importance of heart failure patients’ self-management and help promote their quality of life by enhancing their self-management behavior.


2020 ◽  
Vol 1 (3) ◽  
pp. 104-108
Author(s):  
Meltem REFİKER EGE ◽  
Özlem SORAN

ABSTRACT Introduction: Symptomatic chronic heart failure is an important health problem that limits the daily life, quality of life, effort capacity and physiological condition of the patients. In subset of these patients symptoms persist despite optimal medical management. Enhanced External Counterpulsation (EECP) is a non-invasive Food and Drug Administration (FDA) approved therapy which improves symptoms and clinical outcomes in patients with heart failure. However, there is limited data in Turkish cohort. In this study, we investigated the clinical effects of EECP on multiple parameters in Turkish patients with symptomatic chronic heart failure. Material and Methods: Twenty-one individuals who were diagnosed with symptomatic chronic heart failure (left ventricular ejection fraction ≤40%) with New York Heart Association Class (NYHA) II-III were enrolled in the study. Patients were assigned to 35-session EECP treatment. NYHA classification, SF-36 quality of life questionnaire, Minnesota living heart failure questionnaire, quality of life index cardiac version-IV and Beck depression scale were assessed, and 6-minute walk tests were performed before and after EECP treatment. Results: The mean age of the patients was 57.4±12.5 years. EECP therapy resulted in significant improvement in NYHA functional class, quality of life index, effort capacity and pyhsiological condition in all patients without any adverse event (p=0.001). Conclusion: Enchanced external counterpulsation treatment significantly improved clinical parameters and effort capacity in patients with symptomatic heart failure. These results suggest that EECP is an effective and a safe therapy in Class II-III heart failure patients whose symptoms persist despite optimal medical management. Keywords: heart failure, symptom, quality of life, depression, EECP


2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Paloma Garcimartín ◽  
Monica Astals-Vizcaino ◽  
Neus Badosa ◽  
Anna Linas ◽  
Consol Ivern ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document